EE04036B1 - Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel - Google Patents

Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel

Info

Publication number
EE04036B1
EE04036B1 EEP200000235A EEP200000235A EE04036B1 EE 04036 B1 EE04036 B1 EE 04036B1 EE P200000235 A EEP200000235 A EE P200000235A EE P200000235 A EEP200000235 A EE P200000235A EE 04036 B1 EE04036 B1 EE 04036B1
Authority
EE
Estonia
Prior art keywords
alcohol
alcoholics
composition
craving
preventing
Prior art date
Application number
EEP200000235A
Other languages
English (en)
Estonian (et)
Inventor
Fassi Aldo
Cavazza Claudio
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of EE200000235A publication Critical patent/EE200000235A/xx
Publication of EE04036B1 publication Critical patent/EE04036B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EEP200000235A 1997-10-03 1998-09-18 Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel EE04036B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (en) 1997-10-03 1998-09-18 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Publications (2)

Publication Number Publication Date
EE200000235A EE200000235A (et) 2001-06-15
EE04036B1 true EE04036B1 (et) 2003-06-16

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000235A EE04036B1 (et) 1997-10-03 1998-09-18 Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel

Country Status (27)

Country Link
US (1) US6255346B1 (pl)
EP (1) EP1022960B1 (pl)
JP (1) JP2001518484A (pl)
KR (2) KR100530368B1 (pl)
CN (1) CN1092939C (pl)
AT (1) ATE220860T1 (pl)
AU (1) AU730740B2 (pl)
BG (1) BG64363B1 (pl)
BR (1) BR9812604A (pl)
CA (1) CA2305598C (pl)
CZ (1) CZ291801B6 (pl)
DE (1) DE69806788T2 (pl)
DK (1) DK1022960T3 (pl)
EA (1) EA002177B1 (pl)
EE (1) EE04036B1 (pl)
ES (1) ES2180200T3 (pl)
HU (1) HUP0004336A3 (pl)
IS (1) IS2234B (pl)
IT (1) IT1295408B1 (pl)
MX (1) MXPA00003232A (pl)
NO (1) NO20001688L (pl)
NZ (1) NZ503663A (pl)
PL (1) PL189663B1 (pl)
PT (1) PT1022960E (pl)
SK (1) SK283384B6 (pl)
UA (1) UA66807C2 (pl)
WO (1) WO1999017623A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
DE69618749D1 (de) * 1995-12-01 2002-03-14 Unilever Nv Mikrowellen erhitzbare knusperige Brötchen
ATE187329T1 (de) * 1996-03-04 1999-12-15 Sigma Tau Ind Farmaceuti Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans

Also Published As

Publication number Publication date
SK283384B6 (sk) 2003-06-03
CA2305598C (en) 2007-11-20
AU9366098A (en) 1999-04-27
US6255346B1 (en) 2001-07-03
EE200000235A (et) 2001-06-15
SK4762000A3 (en) 2000-10-09
PT1022960E (pt) 2002-12-31
EP1022960B1 (en) 2002-07-24
CN1092939C (zh) 2002-10-23
DE69806788T2 (de) 2003-04-03
HK1028714A1 (en) 2001-03-02
ITRM970594A1 (it) 1999-04-03
KR20050088499A (ko) 2005-09-06
CA2305598A1 (en) 1999-04-15
DE69806788D1 (de) 2002-08-29
PL339621A1 (en) 2001-01-02
KR20010030928A (ko) 2001-04-16
ES2180200T3 (es) 2003-02-01
NO20001688L (no) 2000-06-02
NO20001688D0 (no) 2000-03-31
NZ503663A (en) 2001-11-30
KR100530368B1 (ko) 2005-11-22
IT1295408B1 (it) 1999-05-12
IS2234B (is) 2007-04-15
EA002177B1 (ru) 2002-02-28
AU730740B2 (en) 2001-03-15
IS5416A (is) 2000-03-24
HUP0004336A3 (en) 2001-07-30
DK1022960T3 (da) 2002-11-04
ATE220860T1 (de) 2002-08-15
BG64363B1 (bg) 2004-12-30
WO1999017623A1 (en) 1999-04-15
EP1022960A1 (en) 2000-08-02
CZ20001207A3 (cs) 2000-11-15
JP2001518484A (ja) 2001-10-16
BR9812604A (pt) 2000-08-01
CN1276704A (zh) 2000-12-13
CZ291801B6 (cs) 2003-05-14
KR100560097B1 (ko) 2006-03-13
UA66807C2 (uk) 2004-06-15
EA200000377A1 (ru) 2000-10-30
BG104286A (en) 2000-11-30
PL189663B1 (pl) 2005-09-30
HUP0004336A2 (hu) 2001-05-28
MXPA00003232A (es) 2004-03-10

Similar Documents

Publication Publication Date Title
EE200000235A (et) Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel
Park et al. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double‐blind, placebo controlled intervention trial
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
BR0008926A (pt) Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
WO2001062290A3 (en) Methods and compositions for improving sleep
BR9810547A (pt) Absorção de minerais pelas células intestinais
KR930000664A (ko) 천연 또는 합성 글리세롤 오일
CA2404387A1 (en) Theanine compositions for promoting sleep
WO2001026666A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
AU1852597A (en) Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid
WO2003013564A3 (en) An herbal composition for the treatment and remedy of bronchial respiratory difficulties
RU95119282A (ru) Композиция ингредиентов для лекарственного средства
CA2395530A1 (en) Calcium formate for use as a phosphorus binder and a dietary supplement
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
DE502005010502D1 (de) Pharmazeutische Zusammensetzung, Verwendung dieser pharmazeutischen Zusammensetzung zur Herstellung eines Medikaments und/oder eines Nahrungsergänzungmittels zur Behandlung von Übergewicht und/oder Symptomen, die mit Übergewicht einhergehen, beim Menschen oder Säugetier, sowie Verfahren zur Herstellung dieser pharmazeutischen Zusammensetzung
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
JP4706174B2 (ja) α−グルコシダーゼ阻害剤
Vargas et al. Getting to the Root (Acorns calamus) of the Problem
JP2002201135A (ja) ラクツロースを含有する上腹部用組成物
Cerrato Ginseng doesn't improve one's mood
CA2325033A1 (en) Use of ribose to treat fibromyalgia
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
JP4604506B2 (ja) α−グルコシダーゼ阻害剤
ATE270095T1 (de) Arzneimittel zur anwendung im mund
ES2134865T3 (es) Uso de extracto de orujo de cerveza para la fabricacion de preparados de administracion oral.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080918